| Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL JA Woyach, AS Ruppert, NA Heerema, W Zhao, AM Booth, W Ding, ... New England Journal of Medicine 379 (26), 2517-2528, 2018 | 998 | 2018 |
| Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL W Ding, BR LaPlant, TG Call, SA Parikh, JF Leis, R He, TD Shanafelt, ... Blood, The Journal of the American Society of Hematology 129 (26), 3419-3427, 2017 | 435 | 2017 |
| Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion … AV Kurtova, K Balakrishnan, R Chen, W Ding, S Schnabl, MP Quiroga, ... Blood, The Journal of the American Society of Hematology 114 (20), 4441-4450, 2009 | 434 | 2009 |
| Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia L Yu, C Liu, J Vandeusen, B Becknell, Z Dai, YZ Wu, A Raval, TH Liu, ... Nature genetics 37 (3), 265-274, 2005 | 290 | 2005 |
| Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression AK Ghosh, CR Secreto, TR Knox, W Ding, D Mukhopadhyay, NE Kay Blood, The Journal of the American Society of Hematology 115 (9), 1755-1764, 2010 | 283 | 2010 |
| Diffuse large B‐cell lymphoma (R ichter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients SA Parikh, KG Rabe, TG Call, CS Zent, TM Habermann, W Ding, JF Leis, ... British journal of haematology 162 (6), 774-782, 2013 | 255 | 2013 |
| Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia TD Shanafelt, T Lin, SM Geyer, CS Zent, N Leung, B Kabat, D Bowen, ... Cancer 109 (11), 2291-2298, 2007 | 207 | 2007 |
| Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications … W Ding, TR Knox, RC Tschumper, W Wu, SM Schwager, JC Boysen, ... Blood, The Journal of the American Society of Hematology 116 (16), 2984-2993, 2010 | 164 | 2010 |
| Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) TD Shanafelt, SA Parikh, PA Noseworthy, V Goede, KG Chaffee, J Bahlo, ... Leukemia & lymphoma 58 (7), 1630-1639, 2017 | 144 | 2017 |
| The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma CS Zent, W Ding, SM Schwager, MS Reinalda, JD Hoyer, DF Jelinek, ... British journal of haematology 141 (5), 615-621, 2008 | 136 | 2008 |
| Endoplasmic Reticulum and cis-Golgi Localization of Human T-Lymphotropic Virus Type 1 p12I: Association with Calreticulin and Calnexin W Ding, B Albrecht, R Luo, W Zhang, JRL Stanley, GC Newbound, ... Journal of virology 75 (16), 7672-7682, 2001 | 130 | 2001 |
| Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes SA Parikh, JF Leis, KG Chaffee, TG Call, CA Hanson, W Ding, ... Cancer 121 (17), 2883-2891, 2015 | 128 | 2015 |
| Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells W Ding, B Albrecht, RE Kelley, N Muthusamy, SJ Kim, RA Altschuld, ... Journal of virology 76 (20), 10374-10382, 2002 | 128 | 2002 |
| Human T-Lymphotropic Virus Type 1 p30IIRegulates Gene Transcription by Binding CREB Binding Protein/p300 W Zhang, JW Nisbet, B Albrecht, W Ding, F Kashanchi, JT Bartoe, ... Journal of virology 75 (20), 9885-9895, 2001 | 126 | 2001 |
| Impact of ibrutinib and idelalisib on the pharmaceutical cost of treating chronic lymphocytic leukemia at the individual and societal levels TD Shanafelt, BJ Borah, HD Finnes, KG Chaffee, W Ding, JF Leis, ... Journal of oncology practice 11 (3), 252-258, 2015 | 125 | 2015 |
| Bi‐directional activation between mesenchymal stem cells and CLL B‐cells: implication for CLL disease progression W Ding, GS Nowakowski, TR Knox, JC Boysen, ML Maas, SM Schwager, ... British journal of haematology 147 (4), 471-483, 2009 | 120 | 2009 |
| Human T-Lymphotropic Virus Type 1 p30IIFunctions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters W Zhang, JW Nisbet, JT Bartoe, W Ding, MD Lairmore Journal of virology 74 (23), 11270-11277, 2000 | 115 | 2000 |
| Activation of Nuclear Factor of Activated T Cells by Human T-Lymphotropic Virus Type 1 Accessory Protein p12I B Albrecht, CD D'Souza, W Ding, S Tridandapani, KM Coggeshall, ... Journal of virology 76 (7), 3493-3501, 2002 | 113 | 2002 |
| The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells S Fiorcari, WS Brown, BW McIntyre, Z Estrov, R Maffei, S O’Brien, ... PloS one 8 (12), e83830, 2013 | 112 | 2013 |
| Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis CS Zent, W Ding, MS Reinalda, SM Schwager, JD Hoyer, DA Bowen, ... Leukemia & lymphoma 50 (8), 1261-1268, 2009 | 109 | 2009 |